Emerging treatments in Castleman disease – a critical appraisal of siltuximab
Jean L Koff, Sagar Lonial Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA Abstract: Castleman disease (CD) is a rare, heterogeneous lymphoproliferative disorder for which no standard of care currently exists. Evidence that the pathophysiology of...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dove Medical Press
2016-01-01
|
| Серія: | Biologics: Targets & Therapy |
| Предмети: | |
| Онлайн доступ: | https://www.dovepress.com/emerging-treatments-in-castleman-disease-ndash-a-critical-appraisal-of-peer-reviewed-article-BTT |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|